SCHEMBL31060955

SCHEMBL31060955

O=C1Nc2ccccc2/C1=C\c1ccc(O)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 4/20 1.00
PLK4 O00444 3/20 1.00
PLK1 P53350 3/20 1.00
RET P07949 1/20 1.00
FLT3 P36888 1/20 1.00
KDR P35968 1/20 0.72
PIM1 P11309 1/20 0.71
APP P05067 4/20 0.67
MAPT P10636 4/20 0.67
SNCA P37840 4/20 0.67
MEN1 O00255 2/20 0.67
ALDH1A1 P00352 2/20 0.67
MAPK1 P28482 2/20 0.67
KMT2A Q03164 2/20 0.67
TDP1 Q9NUW8 2/20 0.67
CTRC Q99895 2/20 0.67
NPC1 O15118 1/20 0.67
GMNN O75496 1/20 0.67
LMNA P02545 1/20 0.67
HPGD P15428 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5470603 1.00 PDGFRB (1.00) PDGFRBPLK4PLK1RETFLT3
SCHEMBL29666461 1.00 PDGFRB (1.00) PDGFRBPLK4PLK1RETFLT3
SCHEMBL5470607 1.00 PDGFRB (1.00) PDGFRBPLK4PLK1RETFLT3
SCHEMBL16442341 1.00 PDGFRB (1.00) PDGFRBPLK4PLK1RETFLT3
SCHEMBL1301398 0.86 PDGFRB (0.76) PDGFRBPLK4PLK1RETFLT3
SCHEMBL29875506 0.86 PDGFRB (0.76) PDGFRBPLK4PLK1RETFLT3
SCHEMBL247890 0.86 PDGFRB (0.76) PDGFRBPLK4PLK1RETFLT3
SCHEMBL247891 0.86 PDGFRB (0.76) PDGFRBPLK4PLK1RETFLT3
SCHEMBL3569608 0.85 PLK4 (0.74) PDGFRBPLK4PLK1RETFLT3
SCHEMBL3569611 0.85 PLK4 (0.74) PDGFRBPLK4PLK1RETFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4662319-A2 PERSONALIZED CRISPR PROFILING FOR CANCER Integrate Bioscience LLC (US) 2025-12-17 EP disclosed
WO-2024168301-A2 PERSONALIZED CRISPR PROFILING FOR CANCER FUNCTION ONCOLOGY, INC. (US) 2024-08-15 WO disclosed